Torrent Pharmaceuticals Shows Strong Fundamentals Amid Recent Evaluation Adjustment
Torrent Pharmaceuticals has recently experienced a notable adjustment in its evaluation, highlighting a shift in technical indicators. The company maintains a strong market position, evidenced by a high return on capital employed and a low debt-to-EBITDA ratio, alongside consistent positive performance and substantial cash reserves.
Torrent Pharmaceuticals has recently undergone an adjustment in its evaluation, reflecting a notable shift in its technical indicators. The company, a significant player in the Pharmaceuticals & Biotechnology sector, has demonstrated a strong market position, supported by a high return on capital employed (ROCE) of 18.68%. This efficiency in management is complemented by a low debt-to-EBITDA ratio of 1.36 times, indicating a robust ability to service its debt obligations.In terms of performance, Torrent Pharmaceuticals has consistently reported positive results over the last nine consecutive quarters, with the latest quarter showing a profit after tax (PAT) of Rs 600.71 crore. The company also boasts substantial cash reserves, with cash and cash equivalents reaching Rs 1,480.00 crore.
The stock has outperformed the BSE500 index over the past three years, achieving a return of 20.14% in the last year alone. Additionally, the stock's performance over various time frames, including a remarkable 392.15% return over the last decade, underscores its resilience and growth potential.
Overall, the recent revision in its score reflects the underlying trends and strong fundamentals that characterize Torrent Pharmaceuticals.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
